Spermosens AB (XSAT:SPERM) Other Operating Expense: kr0.02 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Spermosens AB Other Operating Expense?

Spermosens AB XSAT:SPERM +4.76% Other Operating Expense is kr0.02 Mil as of Mar. 2026.

Spermosens AB's Other Operating Expense for the three months ended in Mar. 2026 was kr-0.01 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was kr0.02 Mil.

Spermosens AB's quarterly Other Operating Expense increased from Sep. 2025 (kr0.00 Mil) to Dec. 2025 (kr0.01 Mil) but then declined from Dec. 2025 (kr0.01 Mil) to Mar. 2026 (kr-0.01 Mil).

Spermosens AB's annual Other Operating Expense declined from Dec. 2023 (kr-0.02 Mil) to Dec. 2024 (kr-0.10 Mil) but then increased from Dec. 2024 (kr-0.10 Mil) to Dec. 2025 (kr-0.03 Mil).

Spermosens AB Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Spermosens AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spermosens AB Other Operating Expense Chart

Spermosens AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial 3.23 0.38 -0.02 -0.10 -0.03

Spermosens AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 0.01 0.00 0.01 -0.01

Spermosens AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of kr0.02 Mil mean?
Spermosens AB (XSAT:SPERM) has a Other Operating Expense of kr0.02 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Spermosens AB and its competitors.
Is Spermosens AB's Other Operating Expense too high?
Spermosens AB's current Other Operating Expense is kr0.02 Mil.
How does Spermosens AB's Other Operating Expense compare to TMO and DHR?
Spermosens AB's Other Operating Expense of kr0.02 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Diagnostics & Research company?
A good Other Operating Expense depends on the Medical Diagnostics & Research industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Spermosens AB and its competitors. Spermosens AB's current Other Operating Expense is kr0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spermosens AB stock overvalued right now?
Spermosens AB (XSAT:SPERM) has a current Other Operating Expense of kr0.02 Mil. The current Other Operating Expense is kr0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Spermosens AB (XSAT:SPERM), the current Other Operating Expense is kr0.02 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Spermosens AB Business Description

Other Exchanges 9R5:Germany
Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment. It is a developer of medical device products for male infertility, individualizing In Vitro Fertilization (IVF) diagnostics and treatment creating a new standard for faster and safer IVF treatments.